Genetically Engineered Biologic Drugs in Management of Children with Bronchial Asthma
Current article represents the modern clinical guidelines on management of severe bronchial asthma (BA) in children and practical use of genetically engineered biologic drugs. Clinical efficacy and safety of omalizumab has its special role. Efficacy analysis was carried out in real-life' clinic...
Saved in:
Main Authors: | Svetlana V. Zaytseva (Author), Anna U. Tomilova (Author), Olga V. Zaytseva (Author), Olga B. Voronina (Author), Olga A. Murtazaeva (Author), Valeriy A. Mukhortykh (Author), Irina N. Tsymbal (Author) |
---|---|
Format: | Book |
Published: |
Union of pediatricians of Russia,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Original article Experience in the use of genetically engineered biological drugs for severe bronchial asthma in the Republic of Sakha (Yakutia)
by: Aleksey V. Danilov, et al.
Published: (2024) -
PEDIATRIC BRONCHIAL ASTHMA: MODERN TREATMENT ASPECTS
by: O.V. Zaitseva, et al.
Published: (2011) -
PEDIATRIC BRONCHIAL ASTHMA: MODERN TREATMENT ASPECTS
by: O.V. Zaitseva, et al.
Published: (2011) -
Acute respiratory infections: the impact of interactions between respiratory viruses on the disease course and outcomes
by: Svetlana V. Zaytsev, et al.
Published: (2023) -
GENETIC FOUNDATIONS OF THE BRONCHIAL ASTHMA
by: A.Yu. Asanov, et al.
Published: (2008)